Genlabs ARA-290 is a small synthetic peptide developed from a part of the erythropoietin (EPO) protein. Unlike EPO, it does not affect red blood cell production but focuses on protecting and repairing damaged tissues.

Researchers study ARA-290 for its potential to reduce inflammation, protect nerves, and help heal injuries, especially in conditions like nerve pain and autoimmune diseases.

How It Works?

ARA-290 works by binding to a special receptor called the Innate Repair Receptor (IRR), which helps start the body’s natural healing processes. This activates signals that reduce inflammation and protect nerve cells from damage without increasing red blood cells. By promoting repair and calming inflammation, ARA-290 supports faster recovery in damaged tissues and improves nerve function in research models.

Dosage :

For research purposes, ARA-290 typically comes as a 10mg powder. Researchers usually reconstitute it with 1–2 mL of sterile water and use a dose of about 1–2 mg per day. It’s commonly given as a subcutaneous injection over 2 to 4 weeks, depending on the study.

Benefits :

• Helps reduce inflammation
• Protects and repairs nerve cells
• Supports healing of damaged tissues
• May reduce pain and improve nerve function

Side Effects :

• Possible mild irritation at the injection site
• Rare headaches or mild fatigue
• No increase in red blood cells (no risk of thickened blood)

Conclusion :

Genlabs ARA-290 is a promising peptide for research focused on nerve protection, inflammation control, and tissue repair. It offers the healing benefits of erythropoietin without affecting blood cells, making it a safe and effective tool for scientific studies.